Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
NHS-Biotin and the Next Era of Protein Design
2026-09-17
NHS-Biotin is more than a labeling reagent: it can serve as an analytical bridge between protein engineering, assembly-state characterization, detection, and purification. This article examines how N-hydroxysuccinimido biotin chemistry can complement emerging peptidisc-assisted nanobody multimerization while keeping translational limitations in view.
-
Phosphatase Inhibitor Cocktail 1: Workflow Guide
2026-09-17
Phosphatase Inhibitor Cocktail 1 is a 100X DMSO-based alkaline phosphatase inhibitor mixture for protein phosphorylation preservation during sample preparation. Its defined composition and storage specifications support phosphoproteomic analysis, Western blotting, and related biochemical workflows, but assay-specific validation remains essential.
-
Pcbp1, Mitochondria, and B Cell Immunity
2026-09-16
Zhu et al. identify the RNA-binding protein Pcbp1 as a posttranscriptional regulator of mitochondrial integrity in B cells. The study connects Pcbp1–Fdxr regulation with complex I function, mitochondrial reactive oxygen species, protein translation, IgM production, and germinal center antibody responses.
-
Midecamycin: Practical Assays for Resistance Research
2026-09-16
Midecamycin is a targeted bacterial protein synthesis inhibitor for Gram-positive screening, ribosome-focused studies, and macrolide resistance workflows. Its susceptibility to multiple glycosylation modifications makes it especially useful for connecting whole-cell antimicrobial results with enzyme-mediated antibiotic inactivation.
-
Ertugliflozin (PF-04971729): Translational Strategy
2026-09-15
A thought-leadership guide to using Ertugliflozin (PF-04971729) in diabetes mellitus research, renal glucose transport studies, weight-loss investigations, and exploratory intestinal inflammation models.
-
JHU-083: A Compartment-Aware Assay Strategy
2026-09-15
JHU-083 is a 6-diazo-5-oxo-L-norleucine precursor for dissecting glutaminase-dependent glutamate biology. This article develops an assay framework that separates cell-selective glutamate effects from downstream oxidative-stress signals, using recent GSTA1 findings to sharpen experimental interpretation.
-
C. difficile Mucus Responses in a Human Intestinal Model
2026-09-14
The reference study introduces a primary human intestinal epithelial cell model that produces physiologic mucus and enables direct analysis of Clostridioides difficile behavior without a resident microbiota. Integrated growth, transcriptomic, biophysical, and metabolic analyses show that mucus is not only a barrier but also a niche that can promote pathogen growth, biofilm formation, and flexible metabolic adaptation.
-
Steroid Lysis of Protoplasts: Spermine Protection
2026-09-14
Smith and Shay used osmotically fragile Sarcina lutea protoplasts to distinguish direct membrane injury from indirect effects of synthetic antimicrobial steroids. Their central finding was that spermine tetrahydrochloride strongly protected protoplasts from steroid-induced lysis, supporting a membrane-centered mechanism and illustrating how protoplast assays can dissect antimicrobial action.
-
Biotin (Vitamin B7): Mechanism & Workflows
2026-09-13
Biotin, also called Vitamin B7 or Vitamin H, is a water-soluble cofactor for five human carboxylases and a high-affinity ligand for avidin and streptavidin. This article separates its metabolic functions from its use in protein biotinylation, defines practical solvent and storage boundaries, and explains why the cited shrimp STING study does not establish a direct role for biotin.
-
Asunaprevir (BMS-650032) HCV Research Workflow
2026-09-12
Build more reliable HCV protease studies with Asunaprevir (BMS-650032), combining genotype-aware dose response, replication readouts, and orthogonal viability controls. The workflow also adapts a high-throughput assay principle from chromatin biology without confusing mechanistic evidence across disease areas.
-
Bobcat339 for TET-Driven DNA Methylation
2026-09-11
Bobcat339 offers a practical chemical perturbation strategy for connecting TET1/TET2 activity with DNA methylation, enhancer state, and osteogenic phenotypes. This workflow translates the UHRF1–TGM2 findings in senile osteoporosis into dose-response, molecular, and multi-omics experiments while emphasizing controls and assay-specific optimization.
-
CLK2 Drives Platinum Resistance in Ovarian Cancer
2026-09-11
The reference study identifies Cdc2-like kinase 2 (CLK2) as a mediator of platinum resistance in ovarian cancer and links this phenotype to phosphorylation of BRCA1 at Ser1423 and enhanced DNA damage repair. Its combination of patient-tissue analysis, functional assays, mechanistic studies, and xenograft validation positions CLK2 as a preclinical target while also clarifying why broad Clk inhibitors require careful interpretation.
-
Small-Molecule Pancreatic Ductal Organoids
2026-09-10
Liao and colleagues report a small-molecule culture strategy that improves the initiation, ductal enrichment, and long-term expansion of pancreatic ductal organoids. The resulting exocrine-focused cultures retain ductal and acinar components, offering a practical platform for studying pancreatic biology, cellular plasticity, and disease-relevant drug responses.
-
EdU Imaging Kits (488) for HCC Proliferation
2026-09-10
EdU Imaging Kits (488) convert S-phase DNA synthesis into a sensitive fluorescence readout for hepatocellular carcinoma research, with imaging and flow cytometry compatibility. This workflow supports HAUS1 perturbation studies while preserving morphology and antigen-binding sites better than harsh BrdU denaturation workflows.
-
Azathramycin A: A Translational Lens on TB Ribosomes
2026-09-09
Azathramycin A offers translational researchers a defined macrolide framework for studying ribosomal target engagement, protein synthesis inhibition, degradation chemistry, resistance, and the boundaries between antibacterial discovery and safety assessment.